Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600128947) titled 'Research on Artificial Intelligence-Based Intervention for Osteoporotic Fracture Risk' on July 28.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The First Affiliated Hospital Of USTC; Anhui Provincal Hospital
Condition:
Osteoporosis
fracture
Intervention:
Standard Care Group:Anti-osteoporotic Treatment
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-08-01
Target Sample Size: Standard Care Group:110;LLM-Assisted Intervention Group (FloraBone Group):110;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html...